Clinical Materials Services
Closed Solicitation Posted
This opportunity was awarded. See the award notice from .
- Solicitation number
- NIHAI75N93021R00011
- Agency
- National Institute of Allergy and Infectious Diseases National Institutes of Health, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
Notice details come from SAM.gov. Updated .
About this opportunity
This solicitation seeks proposals for a clinical materials services contract to be awarded by the National Institute of Allergy and Infectious Diseases. The contract will provide for the management and operation of a cGMP-compliant clinical materials services facility, including receipt, storage, aliquoting, labeling, packaging, repackaging, shipping, acquiring, testing, and disposition of clinical agents and clinical specimens in compliance with federal and local clinical trial regulations. The period of performance is from July 2022 through July 2023 with options to renew for up to six additional years. Offerors must submit proposals by September 21, 2021.
There is no set-aside designation. The primary NAICS code is 541715 and PSC code is R499. The level of effort is amended to 20,235 hours for the base year and options, with pricing to be provided for hourly option quantities exercisable up to two times per year. The contract will support initiatives of the Division of Microbiology and Infectious Diseases within the National Institute of Allergy and Infectious Diseases and primarily perform work within the scope of the institute's mission. Place of performance will be at a cGMP-compliant clinical materials services facility.
Notice text
This contract is for the management and operation of a cGMP-compliant clinical materials services (CMS) facility and a broad range of services which includes but is not limited to receipt, storage, aliquoting, labeling, packaging,repackaging, shipping, acquiring, testing, and disposition of clinical agents and clinical specimens. All work performed under this contract must be done in compliance with federal and/or local clinical trial related regulations. This contract shall be administered and used primarily to support DMID initiatives, however, NIAID may use this contract to support clinical material services for domestic or international clinical research or clinical trials for high-priority NIAID research on a limited basis, if work is within the scope of, and aligned with the NIAID mission.
Attachments
| File | Type | Posted |
|---|---|---|
| Amendment 0001signed.pdf | ||
| Solicitation NIHAI75N93021R00011.pdf |
Notice history
| Notice | Type | Posted |
|---|---|---|
| Clinical Materials Services | Award Notice | |
| Clinical Materials Services | Solicitation | |
| Clinical Materials Services | Pre-Solicitation | |
| Clinical Materials Services | Pre-Solicitation |
On GovTribe
Work this opportunity on GovTribe
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity